VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX)

Q3 2019 13F Holders as of 9/30/2019

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 104M
Number of holders: 31
Total 13F shares, excl. options: 3.11M
Shares change: +80.3K
Total reported value, excl. options: $17.5M
Value change: +$600K
Number of buys: 19
Number of sells: -6
Price: $5.62

Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2019

34 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2019.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.11M shares of 104M outstanding shares and own 3% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1.82M shares), VANGUARD GROUP INC (321K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (224K shares), GEODE CAPITAL MANAGEMENT, LLC (217K shares), MORGAN STANLEY (147K shares), RENAISSANCE TECHNOLOGIES LLC (67.2K shares), JPMORGAN CHASE & CO (41.4K shares), NORTHERN TRUST CORP (38.3K shares), LADENBURG THALMANN FINANCIAL SERVICES INC. (36.5K shares), and Bank of New York Mellon Corp (28K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.